LATS2 and hepatocellular carcinoma: Moreover, miR-103a-3p regulates proliferation and apoptosis by targeting RCAN1 in oral squamous cell carcinoma (OSCC) cells [21], miR-103 promotes HCC growth by inhibiting AKAP12 [35] or by promoting glucose metabolism function [27], and miR-103 promotes metastasis and EMT by inhibiting LATS2 [36].